search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Company insight


Advanced absorbable implants, faster to market


Absorbable medical device development has been hindered by a lack of materials that can exhibit a wide range of tensile moduli similar to the various tissues where devices are implanted. Poly-Med, Inc. has opened the door to solving these challenges through its material portfolio and vertically integrated manufacturing processes.


B


ioabsorbable medical devices offer significant advantages compared to their biostable counterparts, due to their ability to degrade over time by providing support while tissue reinforcement is needed and degrading into biologically safe by-products when it is not.


Although the idea of utilising synthetic degradable materials in medical devices has been used in the clinic for 50 years with the launch of the Dexon suture in 1972 by Davis & Geck, absorbable medical devices have yet to capture large market shares. In part, this is due to the lack of materials and processes suitable to create implants exhibiting mechanical properties matched to the target tissue and indication requirements. Additionally, several medical devices have been recalled due to biocompatibility issues with select long-lasting absorbable materials stemming from poor material selection. Poly-Med, Inc. offers a solution to these challenges by manufacturing next-generation absorbable block copolymers that exhibit increased toughness and biocompatibility compared with traditional linear homopolymers and random copolymers. Poly-Med, Inc. can achieve preferred


Poly-Med is a vertically integrated partner, from bioabsorbable polymer to finished implantable medical device.


mechanical and biological properties by controlling chemical composition and polymer structure.


Increased speed to market with a vertically integrated partner Although the materials from Poly-Med, Inc. offer design advantages over traditional absorbable polymers, these materials can also be more challenging to process into a desired form factor. To circumvent additional challenges with processing these next- generation absorbable polymers, Poly-Med, Inc. can act as a vertically integrated partner to convert these materials into semi-finished and finished medical components, or into packaged medical devices ready for sterilisation.


Poly-Med’s bioabsorbable polymers are designed with segmented block copolymer structures, increasing toughness and elasticity.


Medical Device Developments / www.nsmedicaldevices.com


This vertically integrated supplier network is most advantageous when developing implantable devices such as surgical meshes or sutures, where the team from Poly-Med, Inc. can synthesise the selected polymer, extrude the polymer into a monofilament


fibre or multifilament yarn, and then knit or braid the extruded materials into a desired construct.


Over the past five years, Poly-Med, Inc. has been able to expand its vertically integrated service offerings into advanced manufacturing approaches, such as electrospinning to create nanofibrous textiles and 3D printing to create porous structural elements. Poly-Med, Inc. currently offers GMP-grade filament for fused deposition modelling (FDM) 3D printing that can enable the creation of complex lattice geometries, and offers significant advantages over solid, monolithic designs typical of injection molded parts. More recently, Poly- Med, Inc. has launched its Photoset resin, a biocompatible and absorbable photopolymer that can be crosslinked into 3D-printed parts via commercially available stereolithography (SLA) and digital light processing (DLP) 3D printers. With the combination of an advanced bioresorbable material portfolio and wide array of conversion processes capable of creating a variety of structures and resultant properties, Poly-Med, Inc. can iterate faster to increase an implantable medical device’s speed to market, to ultimately support product development to the benefit of patients who require temporary tissue reinforcement. ●


www.poly-med.com 113


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140  |  Page 141  |  Page 142  |  Page 143  |  Page 144  |  Page 145  |  Page 146